If TRIUMPH-1 confirms 24% or greater weight loss, retatrutide will clearly surpass both semaglutide (approximately 15% to 17%) and tirzepatide (approximately 20% to 22%) in head-to-head comparisons of their important trial data
Practical estimate: plan for about 90 percent yield from each vial
No weight-loss plateau was observed, with participants continuing their weight loss trajectory through 40 weeks
T., & Gurtner, G
You should also contact your medical provider if symptoms are severe, do not improve, or are accompanied by vomiting, diarrhea, fainting, confusion, severe abdominal pain, or an inability to keep fluids down
Phentermine is a short-term stimulant appetite suppressant, while GLP-1s are longer-term metabolic medications